Cardinal Health, Inc.’s recently made public that its CEO, Pharmaceutical Segment WEITZMAN DEBORAH unloaded Company’s shares for reported $3.9 million on Nov 27 ’23. In the deal valued at $106.31 per share,36,642 shares were sold. As a result of this transaction, WEITZMAN DEBORAH now holds 35,202 shares worth roughly $3.77 million.
Then, WEITZMAN DEBORAH sold 6,712 shares, generating $602,805 in total proceeds. Upon selling the shares at $89.81, the CEO, Pharmaceutical Segment now owns 44,202 shares.
Before that, Scherer Mary C. sold 20,695 shares. Cardinal Health, Inc. shares valued at $1,785,358 were divested by the Chief Accounting Officer at a price of $86.27 per share. As a result of the transaction, Scherer Mary C. now holds 10,649 shares, worth roughly $1.14 million.
Leerink Partners initiated its Cardinal Health, Inc. [CAH] rating to an Outperform in a research note published on February 26, 2024; the price target was $125. A number of analysts have revised their coverage, including Argus’s analysts, who increased its forecast for the stock in early February from “a Hold” to “a Buy”. Barclays began covering CAH with “an Overweight” recommendation on January 03, 2024. Wells Fargo started covering the stock on December 14, 2023. It rated CAH as “an Underweight”.
Price Performance Review of CAH
On Monday, Cardinal Health, Inc. [NYSE:CAH] saw its stock jump 1.84% to $107.03. Over the last five days, the stock has lost -2.23%. Cardinal Health, Inc. shares have risen nearly 6.18% since the year began. Nevertheless, the stocks have risen 32.59% over the past one year. While a 52-week high of $116.04 was reached on 03/13/24, a 52-week low of $77.56 was recorded on 01/09/24. SMA at 50 days reached $109.20, while 200 days put it at $99.57. A total of 1.92 million shares were traded, compared to the trading of 1.54 million shares in the previous session.
Levels Of Support And Resistance For CAH Stock
The 24-hour chart illustrates a support level at 106.23, which if violated will result in even more drops to 105.43. On the upside, there is a resistance level at 108.05. A further resistance level may holdings at 109.07. The Relative Strength Index (RSI) on the 14-day chart is 40.48, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -3.41, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 72.46%. Stochastics %K at 10.36% indicates the stock is a buying.
